PD27: Prostate Cancer: Markers II
Monday, May 18, 2026 9:30 AM to 11:30 AM · 2 hr. (America/New_York)
206
Poster and Podium Sessions
Oncology: Prostate
Information
Continuing Medical Education
CME
Monday, May 18
PD27-01: Biochemical recurrence definitions to compare long-term prostate cancer mortality after Radiotherapy or Radical prostatectomy
Monday, May 18, 2026 9:30 AM to 9:38 AM
206
PD27-02: Long-Term Clinical Utility of ExoDx Prostate Scores: 5-Year Outcomes from a Randomized Decision Impact Trial
Monday, May 18, 2026 9:38 AM to 9:46 AM
206
PD27-03: Absolute Length of Gleason Pattern 4 on Biopsy Outperforms Grade Group and Clinical Models in Predicting Adverse Pathology and Biochemical Recurrence in Grade Group 2-4 Prostate Cancer
Monday, May 18, 2026 9:46 AM to 9:54 AM
206
PD27-04: Epigenetic Biomarkers Predict Response to Androgen Deprivation and Identify Novel Therapeutic Targets in Prostate Cancer
Monday, May 18, 2026 9:54 AM to 10:02 AM
206
PD27-05: Assessment of Perineural Invasion on Oncological Outcomes in Prostate Cancer
Monday, May 18, 2026 10:02 AM to 10:10 AM
206
PD27-06: Novel androgen receptor recurring splice junctions in prostate cancer predicts response to abiraterone and overall survival in metastatic prostate cancer.
Monday, May 18, 2026 10:10 AM to 10:18 AM
206
Kendrick Yim · Moffitt Cancer Center
PD27-07: FAP+FN1+CAV1- Cancer Associated Fibroblasts Subtype is associated with aggressive behavior of localized prostate cancer
Monday, May 18, 2026 10:18 AM to 10:26 AM
206
PD27-08: Artificial intelligence-driven urine volatile compound profiling detects low prostate-specific antigen prostate cancer and reveals magnetic resonance imaging invisible lesions
Monday, May 18, 2026 10:26 AM to 10:34 AM
206
PD27-09: A Dual-Compartment Liquid Biopsy lncRNA Signature Reflects PI3K/AKT–Epigenetic Crosstalk and Predicts Clinical Risk in Prostate Adenocarcinoma
Monday, May 18, 2026 10:34 AM to 10:42 AM
206
Poornima Verma
PD27-10: SPP1+ Macrophage/FAP+ Fibroblast Crosstalk Predicts Disease Progression and Immunosuppressive Niche in Prostate Cancer
Monday, May 18, 2026 10:42 AM to 10:50 AM
206
Junlong Zhuang
PD27-11: Effect of 5-Alpha Reductase Inhibitors on the Prostate Health Index and the Need for a Conversion Factor in Clinical Interpretation
Monday, May 18, 2026 10:50 AM to 10:58 AM
206
Jinseok Kang · Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
PD27-12: Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: results from a large-scale longitudinal cohort study
Monday, May 18, 2026 10:58 AM to 11:06 AM
206
PD27-13: Non-invasive molecular phenotyping of prostate cancer using large oncosomes
Monday, May 18, 2026 11:14 AM to 11:22 AM
206
PD27-14: Histopathology-based Artificial Intelligence (AI) Algorithm for Prostate Cancer Tumor Detection and Grading in Multi-institutional Needle Biopsies
Monday, May 18, 2026 11:22 AM to 11:30 AM
206